Lazard Capital Upgrades Incyte (INCY) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 113.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $113.25 | 52 Week High | $118.49 | |||
| Open | $113.25 | 52 Week Low | $55.00 | |||
| Day High | $113.25 | P/E | N/A | |||
| Day Low | $113.25 | EPS | $-0.56 | |||
| Volume | 15 | |||||
